Visium Asset Management’s Quest Diagnostics DGX Stock Holding History

Visium Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-28,872	Closed	-$2.09M	–	965
2015 Q2	$2.09M	Buy	28,872 +21,572	+296%	+$1.59M	0.03%	419
2015 Q1	$561K	Sell	7,300 -7,000	-49%	-$501K	0.01%	661
2014 Q4	$959K	Sell	14,300 -5,441	-28%	-$343K	0.01%	551
2014 Q3	$1.2M	Sell	19,741 -2,159	-10%	-$133K	0.02%	558
2014 Q2	$1.28M	Sell	21,900 -295,112	-93%	-$17.3M	0.02%	491
2014 Q1	$18.4M	Buy	317,012 +260,304	+459%	+$14M	0.3%	71
2013 Q4	$3.04M	Buy	+56,708	New	+$3.36M	0.06%	272

Other funds holding DGX

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Visium Asset Management's DGX Position: Q3 2015 in Review

Visium Asset Management sold out of Quest Diagnostics (DGX) in Q3 2015, closing a stake of 28,872 shares — an estimated $2.09M sold.

Visium Asset Management first reported a position in DGX in Q4 2013 and held it in 7 quarters. The position peaked at $18.4M in Q1 2014. 540 funds tracked by Wall St. Rank hold DGX as of Q3 2015.

Visium Asset Management reported no remaining Quest Diagnostics position as of Q3 2015 after selling out during the quarter.
Visium Asset Management sold 28,872 Quest Diagnostics shares in Q3 2015, an estimated $2.09M.
Visium Asset Management first reported a position in Quest Diagnostics in Q4 2013 and held it in 7 quarters.
Visium Asset Management's Quest Diagnostics position peaked at $18.4M in Q1 2014.
540 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2015.

Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.